Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,861 | 84,806 | 31,087 | 52,891 | 44,200 |
| Marketable Securities | 60,698 | 67,350 | 117,950 | 139,212 | 164,660 |
| Receivables | 31,778 | 37,995 | 31,082 | 26,962 | 37,923 |
| Inventories | 4,672 | 3,476 | 2,769 | 3,043 | 3,105 |
| TOTAL | $184,755 | $208,540 | $198,366 | $233,921 | $263,222 |
| Non-Current Assets | |||||
| PPE Net | 495 | 628 | 719 | 606 | 686 |
| Other Non-Current Assets | 4,226 | 4,809 | 5,373 | 5,911 | 6,052 |
| TOTAL | $4,721 | $5,437 | $6,092 | $6,517 | $6,738 |
| Total Assets | $189,476 | $213,977 | $204,458 | $240,438 | $269,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,783 | 2,797 | 5,028 | 3,123 | 943 |
| Accrued Expenses | 50,105 | 49,809 | 54,851 | 61,394 | 55,713 |
| Other current liabilities | 1,937 | 1,468 | 2,037 | 1,654 | 2,228 |
| TOTAL | $61,493 | $57,619 | $65,341 | $69,479 | $62,079 |
| Non-Current Liabilities | |||||
| Long Term Debt | 94,109 | 93,517 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 193,521 | 194,981 | 308,072 | 307,165 | 308,277 |
| TOTAL | $287,630 | $288,498 | $308,072 | $307,165 | $308,277 |
| Total Liabilities | $349,123 | $346,117 | $373,413 | $376,644 | $370,356 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,358 | 8,316 | 7,851 | 7,675 | 7,639 |
| Common Shares | 13 | 13 | 12 | 12 | 12 |
| Retained earnings | -1,532,680 | -1,500,608 | -1,524,400 | -1,487,038 | -1,445,201 |
| Other shareholders' equity | -222 | -605 | -518 | -161 | -742 |
| TOTAL | $-159,647 | $-132,140 | $-168,955 | $-136,206 | $-100,396 |
| Total Liabilities And Equity | $189,476 | $213,977 | $204,458 | $240,438 | $269,960 |